Rosiglitazone improves myocardial glucose uptake in ischemic regions in patients with type 2 Diabetes. A 16 week randomised, double-blind, placebo-controlled study

Rosiglitazone improves myocardial glucose uptake in ischemic regions in patients with type 2 Diabetes. A 16 week randomised, double-blind, placebo-controlled study

Saved in:
Bibliographic Details
Published in:Journal of nuclear cardiology Vol. 12; no. 2; p. S18
Main Authors: Lautamäki, R. Riikka, Airaksinen, K.E.J., Seppänen, M., Toikka, J., Luotolahti, M., Ball, E., Härkönen, R., Knuuti, J., Stewart, M., Nuutila, P.
Format: Journal Article
Language:English
Published: Elsevier Inc 01-03-2005
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1071-3581
1532-6551
DOI:10.1016/j.nuclcard.2004.12.229